comscoreBreast Cancer Research at ESMO 2021

Breast Cancer Research at ESMO 2021

Dr. Brian Wojciechowski discusses some of the most notable research at the European Society for Medical Oncology Congress 2021.
Oct 21, 2021
00:00
Download
00:00

Dr. Brian Wojciechowski joined us to talk about some of the most notable research at the European Society for Medical Oncology Congress 2021.

Listen to the episode to hear Dr. Wojciechowski explain:

  • what an antibody-drug conjugate is

  • results from the DESTINY-Breast03 study, showing Enhertu more than doubled the 12-month progression-free survival rate compared to Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated

  • results from the BrighTNess study, showing adding carboplatin to chemotherapy before surgery improves progression-free survival.

About the guest
 
Brian Wojciechowski headshot
Brian Wojciechowski, MD

Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.

— Last updated on February 11, 2022, 9:21 PM

 
Lilly Oncology

This content made possible by Lilly Oncology.

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate